Pau Abrisqueta
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 94
- Chronic Lymphocytic Leukemia Research 92
-
- Lymphoma Diagnosis and Treatment 110
- Co-authors
- Francesc Bosch (57 shared papers)Emili Montserrat (15 shared papers)Marta Crespo (23 shared papers)Andrés López (1 shared paper)Cecilia del Carmen Carpio (18 shared papers)Armando López‐Guillermo (8 shared papers)Elı́as Campo (5 shared papers)Eva Giné Soca (11 shared papers)
- Journals
- Blood (45 papers)Hematological Oncology (13 papers)Haematologica (11 papers)British Journal of Haematology (8 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Pau Abrisqueta
160 papers receiving 4.0k citations
Pau Abrisqueta's Hit Papers
Peers
Comparison fields: 5 of 90
- Genetics 1.9k
- Pathology and Forensic Medicine 2.4k
- Oncology 1.6k
- Immunology 787
- Hematology 275
Countries citing papers authored by Pau Abrisqueta
This map shows the geographic impact of Pau Abrisqueta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pau Abrisqueta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pau Abrisqueta more than expected).
Fields of papers citing papers by Pau Abrisqueta
This network shows the impact of papers produced by Pau Abrisqueta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pau Abrisqueta. The network helps show where Pau Abrisqueta may publish in the future.
Co-authors
The 25 scholars most cited alongside Pau Abrisqueta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 341 | |
| 2 | Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies Hit paper breakdown → | 2015 | 327 |
| 3 | 2019 | 190 | |
| 4 | 2010 | 159 | |
| 5 | 2012 | 159 | |
| 6 | 2007 | 151 | |
| 7 | 2009 | 128 | |
| 8 | 2021 | 116 | |
| 9 | 2021 | 111 | |
| 10 | 2009 | 109 | |
| 11 | 2020 | 104 | |
| 12 | 2022 | 102 | |
| 13 | 2017 | 94 | |
| 14 | 2008 | 93 | |
| 15 | 2018 | 85 | |
| 16 | 2018 | 75 | |
| 17 | 2017 | 64 | |
| 18 | 2013 | 54 | |
| 19 | 2011 | 53 | |
| 20 | 2021 | 53 |
About Pau Abrisqueta
Pau Abrisqueta is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 172 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (110 papers), Chronic Lymphocytic Leukemia Research (92 papers), CAR-T cell therapy research (37 papers), Immunodeficiency and Autoimmune Disorders (23 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Viral-associated cancers and disorders (15 papers), CNS Lymphoma Diagnosis and Treatment (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). The work is most often cited by research in Genetics (1.9k citations), Pathology and Forensic Medicine (2.4k citations), Oncology (1.6k citations), Immunology (787 citations) and Hematology (275 citations). Pau Abrisqueta has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Francesc Bosch, Emili Montserrat, Marta Crespo, Andrés López, Cecilia del Carmen Carpio, Armando López‐Guillermo, Elı́as Campo, Eva Giné Soca, Antonio Martı́nez and Noelia Purroy. Their work appears in journals such as Blood, Hematological Oncology, Haematologica, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.